Last reviewed · How we verify
NCT06134869
Open Membrane Technique as an Innovative Minimally Invasive Technique
NA trial testing Bone augmentation in Bone Graft in 16 participants. Completed in 1 February 2023.
1 February 2023
Quick facts
| Lead sponsor | Saint-Joseph University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 16 |
| Start date | 1 January 2019 |
| Primary completion | 1 February 2023 |
| Estimated completion | 1 February 2023 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Bone augmentation
Conditions studied
- Bone Graft — all drugs for Bone Graft →
- Keratinized Tissue — all drugs for Keratinized Tissue →
Sponsor
Saint-Joseph University
Who can join
Adults 18 to 70, any sex, with Bone Graft or Keratinized Tissue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sixteen patients with horizontal deficiencies in the posterior mandible were treated with "the Open Membrane Technique" (OMT). Dense PTFE membranes covering an allograft biomaterial were used without any attempt to passivate the flap. Flap closure with an open wound (membrane exposure) was monitored weekly for up to 6w at the time of membrane removal. At implant placement, soft and hard tissue gains were assessed clinically and radiographically. Bone cores were harvested for histological analysis from the implant preparation sites
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06134869
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bone augmentation
Trials testing the same drug.
- NCT04029324 — Clinical Outcomes of Immediate Implant Placement and Early Implant Placement · NA · unknown
Other recruiting trials for Bone Graft
Currently open trials in the same condition.
- NCT07078331 — Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations · Phase 1, PHASE2 · active not recruiting
- NCT07047131 — Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants · Phase 3 · active not recruiting
Other Saint-Joseph University trials
Trials by the same sponsor.
- NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
- NCT07350746 — A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a · NA · active not recruiting
- NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
- NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
- NCT07525128 — Lateral GBR Using Two Types of Membrane With a Combination of Allograft-xenograft · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06134869 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint-Joseph University
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06134869.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing